CA2563023A1 - Polymer-based stent assembly - Google Patents

Polymer-based stent assembly Download PDF

Info

Publication number
CA2563023A1
CA2563023A1 CA002563023A CA2563023A CA2563023A1 CA 2563023 A1 CA2563023 A1 CA 2563023A1 CA 002563023 A CA002563023 A CA 002563023A CA 2563023 A CA2563023 A CA 2563023A CA 2563023 A1 CA2563023 A1 CA 2563023A1
Authority
CA
Canada
Prior art keywords
cylindrical device
polymeric
stent
diameter
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002563023A
Other languages
French (fr)
Other versions
CA2563023C (en
Inventor
Antoine Lafont
Serge Piranda
Patrick Sabaria
Tahmer Sharkawi
Michel Vert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sahajanand Medical Technologies Pvt Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2563023A1 publication Critical patent/CA2563023A1/en
Application granted granted Critical
Publication of CA2563023C publication Critical patent/CA2563023C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/9522—Means for mounting a stent or stent-graft onto or into a placement instrument
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958—Inflatable balloons for placing stents or stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable

Abstract

Methods for preparing a polymer-based stmt assembly comprising an inflatable balloon catheter and a polymer-based stmt resistant to relaxation-related negative recoil are provided. The methods comprise heating a polymeric cylindrical device which is at a final predetermined shape and diameter to a temperature sufficiently above the glass transition temperature (Tg) of the polymer and for a time sufficient to erase any memory of previous processing of the polymeric cylindrical device and then quenching the polymeric cylindrical device to provide an educated polymeric cylindrical device having a memory of the final predetermined diameter and shape, mounting the educated cylindrical device on an inflatable balloon catheter, reducing the diameter of the educated cylindrical device by heating to a temperature at or slightly above the Tg of the polymer while evenly applying pressure on the exterior surface of the wall of the cylindrical device, and then cooling the cylindrical device below the Tg of the polymer to provide a stmt assembly comprising an inflatable balloon catheter and an expandable, educated, polymeric stmt snugly and stably disposed thereon. Assemblies comprising an inflatable balloon and a polymer based stmt that is substantially resistant to relaxation related recoil mounted snugly on the balloon are also provided.

Claims (26)

1. A method for preparing an assembly for delivering a degradable and bioresorbable polymeric stent that is resistant to relaxation-related recoil to a mammalian subject, comprising:

(a) heating a polymeric cylindrical device which is at a final predetermined radial diameter and wall thickness to a temperature sufficiently above the glass transition temperature (Tg) of the polymer and for a time sufficient to erase memory of previous processing of the polymeric device, wherein the polymeric cylindrical device has a wall defining a first open end, a second open end, and a channel connecting the first and the second open end;

(b) rapidly cooling the polymeric cylindrical device at a temperature below the Tg of the polymer to quench the polymeric cylindrical device and to provide an educated polymeric cylindrical device having a memory of the final predetermined diameter and shape;

(c) forming slits, voids, or open spaces in the wall of the polymeric cylindrical device prior to step (a) or after step (b), wherein the slits, voids, or open spaces are configured to allow a reduction in diameter of the device without substantially altering the wall thickness of the device;

(d) mounting the educated polymeric cylindrical device on an inflatable balloon catheter;

(e) reducing the diameter of the cylindrical device by heating the cylindrical device to a temperature at or slightly above the Tg of the polymer while evenly applying pressure on the exterior surface of the wall of the cylindrical device; and (f) then rapidly cooling the cylindrical device below the Tg of the polymer to provide an assembly comprising a inflatable balloon catheter and an expandable polymeric stent which is substantially resistant to relaxation-related recoil when implanted in the lumen of a tube, duct, or vessel of the mammalian subject or when expanded and stored at 37° C for 4 to 6 weeks.
2. The method of claim 1 wherein the cylindrical device is mounted on a support for maintaining the diameter and shape of the device during step (a) and step (b).
3. The method of claim 1 wherein the stent is formed from a polymer selected from PLA
and stereocopolymers (copolymers composed of L and D units), PLAGA, Poly(lactic-co-glycolic-co-gluconic acid.
4. The method of claim 1 wherein the cylindrical device is reduced to a diameter that is less than the diameter of the lumen of the target duct, tube, or vessel during step (e).
5. The method of claim 1 wherein the wall thickness of the cylindrical device is substantially the same before and after step (e).
6. A method for preparing an assembly for delivering a degradable and bioresorbable polymeric stent into the lumen of a tube, duct, or vessel of a mammalian subject, comprising:

(a) providing a polymeric cylindrical device comprising a wall defining a first open end, a second open end, and a channel connecting said first open end and said second open end, wherein the cylindrical device has a diameter and wall thickness comparable to the final desired diameter and wall thickness of the stent;

(b) educating the device by erasing memory of previous processing of the polymeric device and establishing a memory of the desired diameter; wherein such education is achieved by heating the device to a temperature at least 8 degrees C above the Tg of the polymer;

(c) quenching the device to provide an educated polymeric cylindrical device having a memory of the final predetermined diameter and shape;

(d) forming slits, voids, or open spaces in the wall of the polymeric cylindrical device before or after the device is educated;

(e) mounting the educated polymeric cylindrical device on an inflatable balloon catheter;

(f) crimping the cylindrical device on the inflatable balloon catheter while heating the cylindrical device to a temperature at or slightly above the Tg of the polymer; and (g) then rapidly cooling the cylindrical device below the Tg of the polymer to provide an assembly comprising an inflatable balloon catheter and an expandable polymeric stent which is substantially resistant to relaxation-related recoil when implanted in the lumen of a tube, duct, or vessel of a mammalian subject or when expanded to a final predetermined shape and diameter and stored at 37°C for 4 weeks or more.
7. A method for preparing an assembly for delivering a degradable and bioresorbable polymeric stent into the lumen of a tube, duct, or vessel of a mammalian subject, comprising:

(a) providing a hollow, cylindrical device comprising a wall having slits, openings, or voids therein, wherein the hollow cylindrical device has a radial diameter that is less than the final predetermined diameter of the stent;

(b) heating the polymeric cylindrical device to a temperature close to or above the Tg of the polymer while expanding the tube to the final predetermined diameter;

(c) mounting the cylindrical device on a support for maintaining the cylindrical device at the final predetermined diameter;

(d) heating the mounted cylindrical device to a temperature sufficiently above the glass transition temperature (Tg) of the polymer and for a time sufficient to erase memory of previous processing of the polymeric device;

(e) rapidly cooling the polymeric cylindrical device at a temperature below the Tg of the polymer to quench the polymeric cylindrical device and to provide an educated polymeric cylindrical device having a memory of the final predetermined diameter;

(f) mounting the educated polymeric cylindrical device on an inflatable balloon catheter;

(g) reducing the diameter of the cylindrical device by heating the cylindrical device to a temperature at or slightly above the Tg of the polymer while evenly applying pressure on the exterior surface of the wall of the cylindrical device; and (h) then rapidly cooling the cylindrical device below the Tg of the polymer to provide an assembly comprising a inflatable balloon catheter and an expandable polymeric stent which is substantially resistant to relaxation-related recoil when implanted in the lumen of a tube, duct, or vessel of a mammalian subject or when expanded to a final predetermined shape and diameter and stored at 37°C for 4 weeks or more.
8. The method of claim 6 wherein the stent is formed from a polymer selected from PLA
and stereocopolymers (copolymers composed of L and D units), PLAGA, Poly(lactic-co-glycolic-co-gluconic acid.
9. The method of claim 6 wherein the wall thickness of the cylindrical device is substantially the same before and after step (g).
10. A method for preparing an assembly for delivering a degradable and bioresorbable polymeric stent into the lumen of a tube, duct, or vessel of a mammalian subject, comprising:

(a) providing a polymeric cylindrical device comprising a wall defining a first open end, a second open end, and a channel connecting said first open end and said second open end, and having slits, voids, or open spaces for permitting expansion and contraction of the device without substantially altering the thickness of the wall, wherein the cylindrical device has a radial diameter that is less than the final desired diameter of the stent, (b) expanding the polymeric device to the final desired diameter while heating to a temperature close to or above the Tg of the polymer;

(c) educating the device by erasing memory of previous processing of the polymeric device and establishing a memory of the desired diameter; wherein such education is achieved by heating the device, which is mounted on a support, to a temperature at least 8 degrees C above the Tg of the polymer;

(c) quenching the device to provide an educated polymeric cylindrical device having a memory of the final predetermined diameter and shape;

(d) mounting the educated polymeric cylindrical device on an inflatable balloon catheter;

(e) crimping the cylindrical device on the inflatable balloon catheter while heating the cylindrical device to a temperature at or slightly above the Tg of the polymer; and (f) then rapidly cooling the cylindrical device below the Tg of the polymer to provide an assembly comprising a inflatable balloon catheter and an expandable polymeric stent which is substantially resistant to relaxation-related recoil when implanted in the lumen of a tube, duct, or vessel of a mammalian subject or when expanded to a final predetermined shape and diameter and stored at 37°C for 4 weeks or more.
11. An assembly comprising an inflatable balloon and a polymeric stent prepared in accordance with the method of claim 1, 6, 7, or 10.
12. An assembly for introducing a degradable and bioresorbable stent into a vessel, tube, or duct of a mammalian subject, comprising:

an inflatable balloon catheter, and a stent formed from a degradable polymeric material having a Tg at least 45°
mounted thereon, wherein the stent comprises a wall defining a first open end, a second open end, and a channel connecting the first and second open end, and wherein the wall of stent includes voids, open spaces, or slits that allow the stent to be expanded to a larger diameter, a shorter length, and the same wall thickness when the balloon catheter is inflated or when the stent is heated to a temperature above the Tg of the polymer, and wherein the stent exhibits little to no negative recoil when deployed in the blood vessel of a subject or when expanded to a final predetermined shape and diameter and stored at 37°C for 4 weeks or more; and wherein the assembly has a diameter that allows it to be inserted into a tube, vessel or duct of the subject and advanced to a target site.
13. The assembly of claim 12, wherein the assembly has a diameter that allows the stent to be inserted into a blood vessel of a human subject and advanced to stenotic lesion.
14. The assembly of claim 12 wherein the stent exhibits positive recoil and adaptation to the geometry of the artery when the stent is not fully deployed up to its final diameter during deployment.
15. The assembly of claim 12 wherein the stent is formed from a polymer selected from PLA and stereocopolymers (copolymers composed of L and D units), PLAGA, Poly(lactic-co-glycolic-co-gluconic acid.
16. The assembly of claim 12 wherein the stent is stably mounted on the balloon.
17. The assembly of claim 12 further comprising a retractable sheath covering the exterior surface of the stent.
18. The assembly of claim 12 wherein bioactive agent or tracking agent is disposed within or on a surface of the stent.
19. A method for preparing a degradable and bioresorbable polymeric stent for implantation into the lumen of a tube, duct, or vessel of a mammalian subject, comprising:

(a) heating a polymeric cylindrical device which is at a final predetermined radial diameter and wall thickness to a temperature sufficiently above the glass transition temperature (Tg) of the polymer and for a time sufficient to erase memory of previous processing of the polymeric device, wherein the polymeric cylindrical device has a wall defining a first open end, a second open end, and a channel connecting the first and the second open end;

(b) rapidly cooling the polymeric cylindrical device at a temperature below the Tg of the polymer to quench the polymeric cylindrical device and to provide an educated polymeric cylindrical device having a memory of the final predetermined diameter and shape;
and (c) forming slits, voids, or open spaces in the wall of the polymeric cylindrical device prior to step (a) or after step (b), wherein the stent is resistant to relaxation-related recoil when deployed in the blood vessel of a subject or when expanded to a final predetermined shape and diameter and stored at 37°C for 4 weeks or more.
20. The method of claim 19 wherein the cylindrical device is mounted on a support for maintaining the diameter and shape of the device during step (a) and step (b) .
21. The method of claim 19 wherein the stent is formed from a polymer selected from PLA and stereocopolymers (copolymers composed of L and D units), PLAGA, Poly(lactic-co-glycolic-co-gluconic acid.
22 22. A method for preparing a degradable and bioresorbable polymeric stent that is resistant to relaxation-related recoil when implanted into the lumen of a tube, duct, or vessel of a mammalian subject or when expanded to a final predetermined shape and diameter and stored at 37°C for 4 weeks or more, comprising:

(a) providing a hollow, cylindrical device comprising a wall having slits, openings, or voids therein, wherein the hollow cylindrical device has a radial diameter that is less than the final predetermined diameter of the stent;

(b) heating the polymeric cylindrical device to a temperature close to or above the Tg of the polymer while expanding the tube to the final predetermined diameter;

(c) mounting the cylindrical device on a support for maintaining the cylindrical device at the final predetermined diameter;

(d) heating the mounted cylindrical device to a temperature sufficiently above the glass transition temperature (Tg) of the polymer and for a time sufficient to erase memory of previous processing of the polymeric device; and (e) rapidly cooling the polymeric cylindrical device at a temperature below the Tg of the polymer to quench the polymeric cylindrical device and to provide an educated polymeric cylindrical device having a memory of the final predetermined diameter.
23. The method of claim 22 wherein the stent is formed from a polymer selected from PLA and stereocopolymers (copolymers composed of L and D units), PLAGA, Poly(lactic-co-glycolic-co-gluconic acid.
24. A stent made in accordance with the methods of claims 19 or 22.
25. A stent substantially resistant to relaxation-related recoil when implanted in the lumen of a duct, vessel, or tube of a mammalian subject recoil or when expanded to a final predetermined shape and diameter and stored at 37°C for 4 weeks or more, wherein said stent is formed from a polymer has a Tg of 45°C or greater, and wherein said stent lacks a memory of processing, and has a memory of a final predetermined shape and diameter.
26. A method of reducing the risk of chronic restenosis that can occur in an artery of a patient following PTC angioplasty, comprising:

delivering the assembly of claim 12 to the locus of a stenotic lesion;

inflating the balloon to expand the stent to a diameter equal to or less than the final predetermined diameter; and deflating and withdrawing the balloon.
CA2563023A 2004-04-02 2004-04-02 Polymer-based stent assembly Expired - Fee Related CA2563023C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2004/004133 WO2005096992A1 (en) 2004-04-02 2004-04-02 Polymer-based stent assembly

Publications (2)

Publication Number Publication Date
CA2563023A1 true CA2563023A1 (en) 2005-10-20
CA2563023C CA2563023C (en) 2012-01-24

Family

ID=34957299

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2563023A Expired - Fee Related CA2563023C (en) 2004-04-02 2004-04-02 Polymer-based stent assembly

Country Status (13)

Country Link
US (2) US7731740B2 (en)
EP (1) EP1737387B1 (en)
JP (1) JP4665109B2 (en)
KR (1) KR101098267B1 (en)
CN (1) CN1960684B (en)
AT (1) ATE442822T1 (en)
AU (1) AU2004318159B8 (en)
BR (1) BRPI0418712B8 (en)
CA (1) CA2563023C (en)
DE (1) DE602004023237D1 (en)
ES (1) ES2330849T3 (en)
HK (1) HK1102420A1 (en)
WO (1) WO2005096992A1 (en)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6863683B2 (en) 2001-09-19 2005-03-08 Abbott Laboratoris Vascular Entities Limited Cold-molding process for loading a stent onto a stent delivery system
CN100558321C (en) * 2003-06-16 2009-11-11 南洋理工大学 Polymer Scaffold And Its Manufacturing Methods
ATE442822T1 (en) * 2004-04-02 2009-10-15 Arterial Remodelling Technolog POLYMER-BASED STENT ARRANGEMENT
US20060013853A1 (en) * 2004-07-19 2006-01-19 Richard Robert E Medical devices having conductive substrate and covalently bonded coating layer
US7971333B2 (en) 2006-05-30 2011-07-05 Advanced Cardiovascular Systems, Inc. Manufacturing process for polymetric stents
US8747879B2 (en) * 2006-04-28 2014-06-10 Advanced Cardiovascular Systems, Inc. Method of fabricating an implantable medical device to reduce chance of late inflammatory response
US7731890B2 (en) 2006-06-15 2010-06-08 Advanced Cardiovascular Systems, Inc. Methods of fabricating stents with enhanced fracture toughness
US20140107761A1 (en) 2004-07-26 2014-04-17 Abbott Cardiovascular Systems Inc. Biodegradable stent with enhanced fracture toughness
US20070010736A1 (en) * 2005-05-19 2007-01-11 Biophan Technologies, Inc. Electromagnetic resonant circuit sleeve for implantable medical device
US20070038290A1 (en) * 2005-08-15 2007-02-15 Bin Huang Fiber reinforced composite stents
US20090076594A1 (en) * 2006-03-14 2009-03-19 Patrick Sabaria Method of monitoring positioning of polymer stents
EP2020956A2 (en) 2006-05-26 2009-02-11 Nanyang Technological University Implantable article, method of forming same and method for reducing thrombogenicity
US8333000B2 (en) * 2006-06-19 2012-12-18 Advanced Cardiovascular Systems, Inc. Methods for improving stent retention on a balloon catheter
US8460364B2 (en) 2006-07-20 2013-06-11 Orbusneich Medical, Inc. Bioabsorbable polymeric medical device
WO2008011612A2 (en) 2006-07-20 2008-01-24 Orbusneich Medical, Inc. Bioabsorbable polymeric medical device
EP3009477B1 (en) 2006-07-20 2024-01-24 Orbusneich Medical Pte. Ltd Bioabsorbable polymeric composition for a medical device
US7959942B2 (en) 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
EP2073754A4 (en) 2006-10-20 2012-09-26 Orbusneich Medical Inc Bioabsorbable polymeric composition and medical device background
WO2008084286A2 (en) * 2006-10-25 2008-07-17 Arterial Remodeling Technologies, S.A. Method for expansion and deployment of polymeric structures including stents
US20130150943A1 (en) 2007-01-19 2013-06-13 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US20080177373A1 (en) * 2007-01-19 2008-07-24 Elixir Medical Corporation Endoprosthesis structures having supporting features
US8814930B2 (en) 2007-01-19 2014-08-26 Elixir Medical Corporation Biodegradable endoprosthesis and methods for their fabrication
US8002817B2 (en) * 2007-05-04 2011-08-23 Abbott Cardiovascular Systems Inc. Stents with high radial strength and methods of manufacturing same
US20090163985A1 (en) * 2007-12-19 2009-06-25 Vipul Dave Method of Retaining a Polymeric Stent on an Expansion Member
US8414638B2 (en) * 2008-03-12 2013-04-09 Abbott Cardiovascular Systems Inc. Method for fabricating a polymer stent with break-away links for enhanced stent retenton
US10898620B2 (en) 2008-06-20 2021-01-26 Razmodics Llc Composite stent having multi-axial flexibility and method of manufacture thereof
US8206635B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US8206636B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US8992601B2 (en) 2009-05-20 2015-03-31 480 Biomedical, Inc. Medical implants
EP2432425B1 (en) 2009-05-20 2018-08-08 480 Biomedical, Inc. Medical implant
US9309347B2 (en) 2009-05-20 2016-04-12 Biomedical, Inc. Bioresorbable thermoset polyester/urethane elastomers
US9265633B2 (en) 2009-05-20 2016-02-23 480 Biomedical, Inc. Drug-eluting medical implants
US8888840B2 (en) * 2009-05-20 2014-11-18 Boston Scientific Scimed, Inc. Drug eluting medical implant
US20110319987A1 (en) 2009-05-20 2011-12-29 Arsenal Medical Medical implant
BR112012007955B1 (en) 2009-10-06 2020-07-21 Sahajanand Medical Technologies Private Limited bioresorbable vascular implant
US8808353B2 (en) 2010-01-30 2014-08-19 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds having a low crossing profile
SI2752172T1 (en) * 2010-01-30 2016-10-28 Abbott Cardiovascular Systems Inc. Crush recoverable polymer stents
US8568471B2 (en) 2010-01-30 2013-10-29 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds
US8261423B2 (en) 2010-04-30 2012-09-11 Abbott Cardiovascular Systems Inc. Methods for crimping a polymeric stent onto a delivery balloon
US8844113B2 (en) * 2010-04-30 2014-09-30 Abbott Cardiovascular Systems, Inc. Methods for crimping a polymeric stent scaffold onto a delivery balloon
US9345602B2 (en) * 2010-09-23 2016-05-24 Abbott Cardiovascular Systems Inc. Processes for making crush recoverable polymer scaffolds
CN102429749A (en) * 2011-07-27 2012-05-02 微创医疗器械(上海)有限公司 Novel processing method for biodegradable stent
US8726483B2 (en) 2011-07-29 2014-05-20 Abbott Cardiovascular Systems Inc. Methods for uniform crimping and deployment of a polymer scaffold
CN102379762B (en) * 2011-08-02 2015-03-25 上海微创医疗器械（集团）有限公司 Biodegradable stent with groove and preparation method thereof
CN102247623B (en) * 2011-08-17 2014-07-23 上海微创医疗器械（集团）有限公司 Multilayer degradable stent having shape memory and preparation method thereof
CN102327652A (en) * 2011-09-28 2012-01-25 微创医疗器械(上海)有限公司 Biodegradable stent and preparation method thereof
US8968387B2 (en) 2012-07-23 2015-03-03 Abbott Cardiovascular Systems Inc. Shape memory bioresorbable polymer peripheral scaffolds
JP6267214B2 (en) * 2012-10-25 2018-01-24 アルテリアル・ルモンドラン・テクノロジー・エス・アー Method for crimping a bioresorbable stent
EP2916901B1 (en) 2012-11-12 2020-06-24 Hollister Incorporated Intermittent catheter assembly
WO2014077886A1 (en) 2012-11-14 2014-05-22 Hollister Incorporated Disposable catheter with selectively degradable inner core
WO2014188437A2 (en) 2013-05-23 2014-11-27 S.T.S. Medical Ltd. Shape change structure
EP3862031B1 (en) 2013-11-08 2023-08-09 Hollister Incorporated Oleophilic lubricated catheters
US10420859B2 (en) 2013-12-12 2019-09-24 Hollister Incorporated Flushable catheters
EP3079752B1 (en) 2013-12-12 2020-04-01 Hollister Incorporated Flushable catheters
CA2923676C (en) 2013-12-12 2020-10-13 Hollister Incorporated Flushable catheters
DK3079748T3 (en) 2013-12-12 2020-08-17 Hollister Inc EXCLUSIVE DECOMPOSITION CATHETER
US9855156B2 (en) 2014-08-15 2018-01-02 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9259339B1 (en) 2014-08-15 2016-02-16 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9730819B2 (en) 2014-08-15 2017-08-15 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9480588B2 (en) 2014-08-15 2016-11-01 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9931787B2 (en) 2014-09-18 2018-04-03 Abbott Cardiovascular Systems Inc. Crimping polymer scaffolds
US9795497B2 (en) 2014-09-18 2017-10-24 Abbott Cardiovascular Systems Inc. Thermal processing of polymer scaffolds
WO2016084087A2 (en) 2014-11-26 2016-06-02 S.T.S. Medical Ltd. Shape change structure for treatment of nasal conditions including sinusitis
EP3310404B1 (en) 2015-06-17 2024-03-13 Hollister Incorporated Selectively water disintegrable materials and catheters made of such materials
US20160374838A1 (en) * 2015-06-29 2016-12-29 Abbott Cardiovascular Systems Inc. Drug-eluting coatings on poly(dl-lactide)-based scaffolds
US10143573B2 (en) * 2015-12-17 2018-12-04 Abbott Cardiovascular Systems Inc. Thin-walled scaffolds having flexible distal end
US9956099B2 (en) 2015-12-17 2018-05-01 Abbott Cardiovascular Systems Inc. Thin-walled scaffolds having reduced crimp profile and carrying radiopaque markers
US9861507B2 (en) * 2015-12-17 2018-01-09 Abbott Cardiovascular Systems Inc. Thin-walled scaffolds having modified marker structure near distal end
US10010653B2 (en) * 2016-02-05 2018-07-03 Abbott Cardiovascular Systems Inc. Methods for increasing coating strength to improve scaffold crimping yield
US11622872B2 (en) 2016-05-16 2023-04-11 Elixir Medical Corporation Uncaging stent
CN113143536B (en) 2016-05-16 2022-08-30 万能医药公司 Opening support

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927838A (en) * 1987-07-10 1990-05-22 Hoffman-La Roche Inc. Pyridine compounds which are useful in treating a disease state characterized by an excess of platelet activating factors
JP2561853B2 (en) * 1988-01-28 1996-12-11 株式会社ジェイ・エム・エス Shaped memory molded article and method of using the same
US6248129B1 (en) 1990-09-14 2001-06-19 Quanam Medical Corporation Expandable polymeric stent with memory and delivery apparatus and method
US5258020A (en) 1990-09-14 1993-11-02 Michael Froix Method of using expandable polymeric stent with memory
US5163952A (en) 1990-09-14 1992-11-17 Michael Froix Expandable polymeric stent with memory and delivery apparatus and method
AU650700B2 (en) 1991-03-08 1994-06-30 Keiji Igaki Luminal stent, holding structure therefor and device for attaching luminal stent
CA2087132A1 (en) 1992-01-31 1993-08-01 Michael S. Williams Stent capable of attachment within a body lumen
US5212188A (en) * 1992-03-02 1993-05-18 R. J. Reynolds Tabacco Company Method for treatment of neurodegenerative diseases
US5716410A (en) 1993-04-30 1998-02-10 Scimed Life Systems, Inc. Temporary stent and method of use
US5629077A (en) 1994-06-27 1997-05-13 Advanced Cardiovascular Systems, Inc. Biodegradable mesh and film stent
AU3783295A (en) 1994-11-16 1996-05-23 Advanced Cardiovascular Systems Inc. Shape memory locking mechanism for intravascular stent
US5616707A (en) * 1995-01-06 1997-04-01 Crooks; Peter A. Compounds which are useful for prevention and treatment of central nervous system disorders
US5731314A (en) * 1995-01-06 1998-03-24 Bencherif; Merouane Pharamceutical compositions for prevention and treatment of tourette's syndrome
US5604231A (en) * 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5597919A (en) * 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5824692A (en) * 1995-01-06 1998-10-20 Lippiello; Patrick Michael Pharmaceutical compositions for prevention and treatment of central nervous system disorders
US5585388A (en) * 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
US5616717A (en) * 1995-04-20 1997-04-01 Boehringer Ingelheim Pharmaceuticals, Inc. Process for the preparation of pure enantiomers of 1-(2-pyridyl)-2-cyclohexylethylamine
US5616716A (en) * 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
US5663356A (en) * 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds
US6979695B2 (en) * 1996-04-23 2005-12-27 Targacept, Inc. Compounds capable of activating cholinergic receptors
AU727976B2 (en) * 1996-04-23 2001-01-04 Targacept, Inc. Pharmaceutical compositions for prevention and treatment of central nervous system disorders
US20020052497A1 (en) * 2000-03-09 2002-05-02 Targacept, Inc. Compounds capable of activating cholinergic receptors
US6166048A (en) * 1999-04-20 2000-12-26 Targacept, Inc. Pharmaceutical compositions for inhibition of cytokine production and secretion
US5670161A (en) * 1996-05-28 1997-09-23 Healy; Kevin E. Biodegradable stent
US5629325A (en) * 1996-06-06 1997-05-13 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
US5868781A (en) * 1996-10-22 1999-02-09 Scimed Life Systems, Inc. Locking stent
US5833651A (en) 1996-11-08 1998-11-10 Medtronic, Inc. Therapeutic intraluminal stents
US5980551A (en) 1997-02-07 1999-11-09 Endovasc Ltd., Inc. Composition and method for making a biodegradable drug delivery stent
US5811442A (en) * 1997-02-21 1998-09-22 Bencherif; Merouane Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow
US5861423A (en) * 1997-02-21 1999-01-19 Caldwell; William Scott Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
US6531606B1 (en) * 1997-02-21 2003-03-11 Targacept, Inc. Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
US5957975A (en) 1997-12-15 1999-09-28 The Cleveland Clinic Foundation Stent having a programmed pattern of in vivo degradation
PL342996A1 (en) 1998-02-23 2001-07-16 Mnemoscience Gmbh Shape memory polymers
HU222543B1 (en) * 1998-02-23 2003-08-28 Massachusetts Institute Of Technology Biodegradable shape memory polymers
US6287314B1 (en) 1998-04-21 2001-09-11 Advanced Cardiovascular Systems, Inc. Stent deploying catheter system
US6232316B1 (en) * 1998-06-16 2001-05-15 Targacept, Inc. Methods for treatment of CNS disorders
US20050131034A1 (en) * 1998-06-16 2005-06-16 Caldwell William S. Compounds capable of activating cholinergic receptors
US6218383B1 (en) * 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
JP4889151B2 (en) 1998-09-08 2012-03-07 株式会社 京都医療設計 Vascular stent
US6262124B1 (en) * 1998-10-22 2001-07-17 Gary Maurice Dull Pharmaceutical compositions and methods for use
US6455554B1 (en) * 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
US6338739B1 (en) 1999-12-22 2002-01-15 Ethicon, Inc. Biodegradable stent
US6527801B1 (en) 2000-04-13 2003-03-04 Advanced Cardiovascular Systems, Inc. Biodegradable drug delivery material for stent
US6485512B1 (en) 2000-09-27 2002-11-26 Advanced Cardiovascular Systems, Inc. Two-stage light curable stent and delivery system
US6607553B1 (en) 2000-11-17 2003-08-19 B. Braun Medical, Inc. Method for deploying a thermo-mechanically expandable stent
US7048939B2 (en) 2001-04-20 2006-05-23 The Board Of Trustees Of The Leland Stanford Junior University Methods for the inhibition of neointima formation
US7128755B2 (en) 2001-06-01 2006-10-31 Texas Stent Technologies, Inc. Expandable biodegradable polymeric stents for combined mechanical support and pharmacological or radiation therapy
WO2003011212A2 (en) 2001-08-02 2003-02-13 Cornell Research Foundation, Inc. Biodegradable polyhydric alcohol esters
US7572287B2 (en) * 2001-10-25 2009-08-11 Boston Scientific Scimed, Inc. Balloon expandable polymer stent with reduced elastic recoil
US20030216804A1 (en) 2002-05-14 2003-11-20 Debeer Nicholas C. Shape memory polymer stent
US20040034405A1 (en) 2002-07-26 2004-02-19 Dickson Andrew M. Axially expanding polymer stent
US20040045645A1 (en) * 2002-09-10 2004-03-11 Scimed Life Systems, Inc. Shaped reinforcing member for medical device and method for making the same
DE60336158D1 (en) * 2002-10-11 2011-04-07 Univ Connecticut ON SEMICRISTALLINE THERMOPLASTIC POLYURETHANES BASED FOR NANOSTRUCTURED HARD SEGMENTS BASED FORM MEMORY PILARMERS
ATE442822T1 (en) 2004-04-02 2009-10-15 Arterial Remodelling Technolog POLYMER-BASED STENT ARRANGEMENT

Also Published As

Publication number Publication date
BRPI0418712A (en) 2007-09-11
US20100204778A1 (en) 2010-08-12
EP1737387A1 (en) 2007-01-03
US7731740B2 (en) 2010-06-08
ES2330849T3 (en) 2009-12-16
JP2007530187A (en) 2007-11-01
HK1102420A1 (en) 2007-11-23
US9283094B2 (en) 2016-03-15
DE602004023237D1 (en) 2009-10-29
ATE442822T1 (en) 2009-10-15
WO2005096992A1 (en) 2005-10-20
CN1960684B (en) 2013-11-06
CA2563023C (en) 2012-01-24
JP4665109B2 (en) 2011-04-06
BRPI0418712B8 (en) 2021-06-22
EP1737387B1 (en) 2009-09-16
CN1960684A (en) 2007-05-09
AU2004318159B8 (en) 2011-05-26
BRPI0418712B1 (en) 2019-06-18
AU2004318159A1 (en) 2005-10-20
KR20070018910A (en) 2007-02-14
AU2004318159B2 (en) 2011-04-07
US20060058863A1 (en) 2006-03-16
KR101098267B1 (en) 2011-12-26

Similar Documents

Publication Publication Date Title
CA2563023A1 (en) Polymer-based stent assembly
JP2007530187A5 (en)
CN103476365B (en) For manufacturing the method that conquassation can recover polymer support
US5980532A (en) Stent installation method using balloon catheter having stepped compliance curve
JP4279891B2 (en) Method of manufacturing a system for treating a vascular condition
EP2004104B1 (en) Improved methods of polymeric stent surface smoothing and resurfacing to reduce biologically active sites
US20090105800A1 (en) Methods of minimizing stent contraction following deployment
CA2162970C (en) Shape memory locking mechanism for intravascular stent
EP1470798B1 (en) Method for stent retention using an adhesive
US20080033524A1 (en) Heated balloon assembly for delivery of polymeric stents
EP0904124A1 (en) Focalized intraluminal balloons
CA2501617A1 (en) Expandable polymeric endoprosthesis with shape memory
JPH02255157A (en) Bioorgan expander and bioorgan expanding appliance
US20090133817A1 (en) Stent manufacturing methods
JP5282069B2 (en) Polymer-based stent assembly
JP5675756B2 (en) Polymer-based stent assembly
KR20170094820A (en) Medical catheter device
JP2013046829A (en) Polymer base stent assembly
AU722466B2 (en) Shape memory locking mechanism for intravascular stent

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20210406